2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Acute Coronary Syndrome in 1 studies
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source
Acute Coronary Syndrome: An episode of MYOCARDIAL ISCHEMIA that generally lasts longer than a transient anginal episode that ultimately may lead to MYOCARDIAL INFARCTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, B | 1 |
| Peng, Y | 1 |
| Dong, J | 1 |
| Lin, J | 1 |
| Wu, C | 1 |
| Su, Y | 1 |
| Fang, H | 1 |
| Wang, L | 1 |
| Huang, K | 1 |
| Li, D | 1 |
1 other study available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Acute Coronary Syndrome
| Article | Year |
|---|---|
Human platelets express functional thymic stromal lymphopoietin receptors: a potential role in platelet activation in acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Angina Pectoris; Blood Platelets; Chromones; Cytokines; Enzyme Inhibi | 2013 |